This site contains information about cannabis genetics. Access is strictly reserved for adults.
By accessing this site, you confirm you are of legal age in your jurisdiction.
Twenty years of cultivation. The conviction that genetics — not flower — is the true value.
2003
Beginning of a 20+ year trajectory covering all cultivation methods: greenhouse, outdoor, indoor (soil / coco / hydro / aero), SCROG, LST, one-bud, organic and non-organic. Fribourg, Switzerland.
2016
Fribourg — a pioneering CBD flower brand in the Swiss market. First mover advantage in a newly forming regulatory landscape. Rapid market traction.
2020
SwissBud SARL liquidated by forced bankruptcy during the COVID period — a legal dispute despite payment having been made. The experience clarified the conviction: flower is ephemeral. Genetics are permanent. Total reconversion toward breeding and seed genetics begins.
2022
Development of the APEX DNA concept. The five-branch commercial model is designed. The three proprietary mother plants — Erdbeer, Purpurea Ticinensis, Alpine Rocket — are consolidated as the core genetic asset. Breeding protocols formalised.
2025
The documented genealogy of the Fraise 1994 lineage is presented to the University of Fribourg research team — a significant milestone in academic recognition of Swiss cannabis heritage.
2026
APEX DNA Sàrl formally launched. Bicephalous structure: Swiss entity (B1–B3 CBD/CBG) + Austrian entity (B4–B5 THC markets). Seven varieties available. The custodian of Swiss genetic heritage is open.
Built over two decades. These connections form the foundation of APEX DNA's genetic intelligence.
Jean-Pierre Egger
Cantonal Cannabis Pioneer · Murist, FR
Helvetic Seeds
Custodian · Erdbeer Lineage
Rif Valley / Ketama
Landrace Network · Morocco
Dinafem Seeds
Historical European Breeder
University of Fribourg
Academic Partner · Botanical Research
Felix Kautz / Owls
Heritage Source · Purpurea Ticinensis
| Entity | Country | Headquarters | Branches | Market |
|---|---|---|---|---|
| APEX DNA Sàrl | 🇨🇭 Switzerland | Fribourg | B1 · B2 · B3 | CBD/CBG · Swiss + EU markets |
| Collection Entity | 🇦🇹 Austria | TBD | B4 · B5 | THC >1% · USA · Canada · Germany · Legal markets |
These mother plants exist nowhere else in this form. No catalogue inflation. No volume. Every variety earns its place.
Each seed exits a documented protocol. HPLC-analysed. Germination-tested. Traceable to a specific mother, generation and date.
Precision, reliability, alpine nature, historical depth. Switzerland as origin is not marketing — it is the genetic reality of these varieties.